美国贝塞斯达消息:具有在眼内扩张和“治疗”作用的一种新型可注射的眼内晶状体(IOL)可能不久使白内障病人在手术后不用戴厚如“瓶底”的眼镜。这一技术是犹他盐湖城卫生科学中心犹他大学眼内晶状体研究中心正在估价的两种囊内手术之一。据犹他大学医学院眼科及病理科教授Da-vid Apple称,两种白内障手术似乎都能减少角膜的损伤,并可使白内障手术病人避免出现 Bethesda, United States: A new injectable intraocular lens (IOL) that has the role of intraocular expansion and “healing” may soon allow cataract patients to wear glasses that are thick “bottom” after surgery. The technology is one of two types of intracapsular surgery under evaluation at the University of Utah Eye Surgery Center at Salt Lake City Health Sciences Center in Utah. According to Da-vid Apple, a professor of ophthalmology and pathology at the University of Utah School of Medicine, both cataract procedures seem to reduce corneal damage and prevent cataract surgery patients from appearing